Renal and cardiac responses in a phase 1/2 study of AT-02, a novel pan-amyloid depleter IgG fusion protein for the treatment of patients with AL amyloidosis Jan 23, 2026
Diagnostic Performance of Cardiac and Whole-Body 124I-evuzamitide (AT-01) PET/MRI in Systemic Amyloidosis Sep 8, 2025
A Tale of Two Tracers – A Qualitative Comparison of the PET and SPECT Amyloid-Imaging Agents, 124I-evuzamitide (AT-01) and 99mTc-p5+14 (AT-05), that are Derived from the Same Synthetic Amyloid-Binding Peptide, p5+14 Sep 8, 2025
First-in-Human Cardiac and Whole-Body 124I-evuzamitide (AT-01) PET/MRI in Systemic Amyloidosis May 28, 2024
Changes in Organ-Specific Amyloid Load Assessed by Serial PET/CT Imaging of Iodine (124I) Evuzamitide – Correlation with Serum Biomarkers May 28, 2024
